Absorption Systems opens renovated AAALAC-accredited GLP surgical suite for medical device testing

Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company’s facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well. The company works with customers to rapidly test devices and biomaterials for safety and biocompatibility. Where appropriate, Absorption Systems studies comply with U.S. Food and Drug Administration (FDA) and Organisation for Economic Co-operation and Development (OECD) regulations.

The company’s AAALAC-accredited, GLP-compliant facility is equipped to offer medical device clients a broad range of services, experimental models and surgical capabilities. The new, 1,100-square-foot surgical suite includes a C-arm high-resolution digital fluoroscopy imaging system, new surgical tables, anesthesia systems, an observation room and much more. In vivo preclinical studies can include testing of orthopedic implants, cardiovascular stents and implants, bone healing, tissue engineering, drug delivery, corneal healing, wound healing and general surgery. Absorption Systems’ GLP bioanalytical laboratory supports testing of drug-eluting devices. Benefits of working with Absorption Systems include access to specialized technical staff and equipment, rapid turnaround time and competitive pricing. Absorption Systems’ facility is also available for contract leasing.

“For years, we’ve been a leader in helping our customers move drugs from the benchtop to the clinic,” commented Patrick M. Dentinger, president and CEO of Absorption Systems. “With our state-of-the-art surgical suite, we expand our capability to assist clients in advancing ‘concepts’ into safe and effective medical devices by moving them rapidly toward IDE, 510(k) or PMA regulatory filings. We expect that our new facility, coupled with our renowned customer service, will factor into medical device manufacturers’ decisions when selecting Absorption Systems for testing.”

SOURCE Absorption Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Ketogenic diet may show more promising results than Mediterranean diets in short-term type 2 diabetes management